{"podcast":{"title":"Startup Insider","slug":"startup-insider-6744721","podcast_index_feed_id":6744721,"rss_url":"https://feeds.simplecast.com/ZQdsoEnZ","website_url":"https://startup-insider.com/alle-podcast-folgen/","image_url":"https://image.simplecastcdn.com/images/97a167f4-fd47-43be-a3f7-e056c5f93dd5/32d5ce35-5beb-4204-a2d7-182b3a75b072/3000x3000/cover-20startup-20insider-20podcast.jpg?aid=rss_feed","author":"Startup Insider GmbH (Jan Thomas)","episode_count":3000,"summary":"Startup Insider ist der tägliche Podcast für alle, die verstehen wollen, was in der Startup-, Tech- und Investment-Szene wirklich passiert. Wir liefern dir jeden Werktag kompakte Nachrichten, Einordnungen und Interviews zu Startups, Finanzierungsrunden, Exits und neuen Technologien – aus Deutschland und international. Mit herausragenden Gästen und festen Formaten wie Startup News, Investments & Exits, Startup Spotlight und Checkpoint bleibst du informiert, ohne Zeit zu verlieren.","last_synced_at":null,"page_url":"https://stenobird.com/podcast/startup-insider-6744721"},"episode":{"title":"3D-Bioprinting: Gewebeimplantate aus dem Drucker – Alexander Leutner (Cellbricks Therapeutics)","slug":"3d-bioprinting-gewebeimplantate-aus-dem-drucker-alexander-leutner-cellbricks-therapeutics","published_at":"2026-04-29T11:00:00+00:00","page_url":"https://stenobird.com/podcast/startup-insider-6744721/3d-bioprinting-gewebeimplantate-aus-dem-drucker-alexander-leutner-cellbricks-therapeutics","show_page_url":"https://stenobird.com/podcast/startup-insider-6744721","url":"https://startup-insider.com/alle-podcast-folgen/","audio_url":"https://afp-912057-injected.calisto.simplecastaudio.com/d2790bdf-c937-4878-8f59-941f6b6b4ef5/episodes/fa45544e-fe04-41c7-b524-6739ba00fcd0/audio/128/default.mp3?aid=rss_feed&awCollectionId=d2790bdf-c937-4878-8f59-941f6b6b4ef5&awEpisodeId=fa45544e-fe04-41c7-b524-6739ba00fcd0&feed=ZQdsoEnZ","summary":"Cellbricks Therapeutics is developing a 3D-bioprinting platform to manufacture functional human tissue implants. The company aims to progress from wound healing applications to complex organ replacement through strategic pharmaceutical partnerships.","meta_description":"Explore the future of regenerative medicine with Cellbricks Therapeutics, a Berlin-based deep-tech startup mastering 3D-bioprinting for tissue implants.","key_points":["Main idea: Cellbricks utilizes a light-based bioprinting process to stabilize cells within a hydrogel structure","Practical takeaway: The platform model allows for scalable applications ranging from wound healing to breast reconstruction and organ replacement","Business model: The company pursues co-development deals with large pharma to leverage massive upfront and milestone payments","Failure mode: High R&D costs and the intense regulatory requirements of the biotech sector necessitate significant capital and strategic partnerships","Strategic vision: Using a platform approach enables the company to launch multiple assets and diversify therapeutic use cases"],"chapters":[{"start_ms":60000,"title":"Introduction to Cellbricks","summary":"An introduction to Alexander Leutner and the moonshot vision of biofabricated human tissue implants."},{"start_ms":220000,"title":"The Roadmap to Organ Replacement","summary":"Discussing the transition from simpler tissue manufacturing to the ultimate goal of complex organ replacement."},{"start_ms":530000,"title":"The Bioprinting Process","summary":"Technical details on using light to cure functionalized biomaterials into a cell-embedded hydrogel."},{"start_ms":1010000,"title":"Platform Assets and Use Cases","summary":"How the technology scales from wound healing to advanced tissue reconstruction and dual-use defense applications."},{"start_ms":1160000,"title":"The Pharma Partnership Model","summary":"Analyzing the economics of co-development deals, milestone payments, and the symbiosis between startups and Big Pharma."},{"start_ms":1320000,"title":"Scaling and Fundraising","summary":"Insights into managing growth, securing venture capital, and navigating the deep-tech funding landscape in Germany."},{"start_ms":1950000,"title":"Impact and Future Outlook","summary":"The broader implications of bioprinting for the deep-tech ecosystem, investors, and the global medical community."}],"topics":["3D-Bioprinting","Regenerative Medicine","Deep Tech","Biotechnology","Tissue Engineering","Pharmaceutical Partnerships","Medical Innovation","Berlin Startups"],"duration_seconds":1964,"processing_state":"processed","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/startup-insider-6744721/episodes/3d-bioprinting-gewebeimplantate-aus-dem-drucker-alexander-leutner-cellbricks-therapeutics/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/startup-insider-6744721/3d-bioprinting-gewebeimplantate-aus-dem-drucker-alexander-leutner-cellbricks-therapeutics.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}